These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 18634833)

  • 1. Phosphorylation, lipid raft interaction and traffic of alpha-synuclein in a yeast model for Parkinson.
    Zabrocki P; Bastiaens I; Delay C; Bammens T; Ghillebert R; Pellens K; De Virgilio C; Van Leuven F; Winderickx J
    Biochim Biophys Acta; 2008 Oct; 1783(10):1767-80. PubMed ID: 18634833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Posttranslational Modifications and Clearing of α-Synuclein Aggregates in Yeast.
    Popova B; Kleinknecht A; Braus GH
    Biomolecules; 2015 Apr; 5(2):617-34. PubMed ID: 25915624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel suppressors of alpha-synuclein toxicity identified using yeast.
    Liang J; Clark-Dixon C; Wang S; Flower TR; Williams-Hart T; Zweig R; Robinson LC; Tatchell K; Witt SN
    Hum Mol Genet; 2008 Dec; 17(23):3784-95. PubMed ID: 18772193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation does not prompt, nor prevent, the formation of alpha-synuclein toxic species in a rat model of Parkinson's disease.
    Azeredo da Silveira S; Schneider BL; Cifuentes-Diaz C; Sage D; Abbas-Terki T; Iwatsubo T; Unser M; Aebischer P
    Hum Mol Genet; 2009 Mar; 18(5):872-87. PubMed ID: 19074459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of parkin promotes lipid rafts-dependent endocytosis through accumulating caveolin-1: implications for Parkinson's disease.
    Cha SH; Choi YR; Heo CH; Kang SJ; Joe EH; Jou I; Kim HM; Park SM
    Mol Neurodegener; 2015 Dec; 10():63. PubMed ID: 26627850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aggregate clearance of α-synuclein in Saccharomyces cerevisiae depends more on autophagosome and vacuole function than on the proteasome.
    Petroi D; Popova B; Taheri-Talesh N; Irniger S; Shahpasandzadeh H; Zweckstetter M; Outeiro TF; Braus GH
    J Biol Chem; 2012 Aug; 287(33):27567-79. PubMed ID: 22722939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aggresome formation and segregation of inclusions influence toxicity of α-synuclein and synphilin-1 in yeast.
    Swinnen E; Büttner S; Outeiro TF; Galas MC; Madeo F; Winderickx J; Franssens V
    Biochem Soc Trans; 2011 Oct; 39(5):1476-81. PubMed ID: 21936837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synphilin-1 enhances α-synuclein aggregation in yeast and contributes to cellular stress and cell death in a Sir2-dependent manner.
    Büttner S; Delay C; Franssens V; Bammens T; Ruli D; Zaunschirm S; de Oliveira RM; Outeiro TF; Madeo F; Buée L; Galas MC; Winderickx J
    PLoS One; 2010 Oct; 5(10):e13700. PubMed ID: 21060871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-Terminal Tyrosine Residue Modifications Modulate the Protective Phosphorylation of Serine 129 of α-Synuclein in a Yeast Model of Parkinson's Disease.
    Kleinknecht A; Popova B; Lázaro DF; Pinho R; Valerius O; Outeiro TF; Braus GH
    PLoS Genet; 2016 Jun; 12(6):e1006098. PubMed ID: 27341336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clearance and phosphorylation of alpha-synuclein are inhibited in methionine sulfoxide reductase a null yeast cells.
    Oien DB; Shinogle HE; Moore DS; Moskovitz J
    J Mol Neurosci; 2009 Nov; 39(3):323-32. PubMed ID: 19653131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression levels of the D686N Parkinson's disease mutation in VPS35 induces α-synuclein-dependent toxicity in yeast.
    Huang Y; Chen X; He X; Guo C; Sun X; Liang F; Long S; Lu X; Feng L; Guo W; Zeng Y; Pei Z
    Mol Med Rep; 2017 Jul; 16(1):254-262. PubMed ID: 28487947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parkinson disease mutant E46K enhances α-synuclein phosphorylation in mammalian cell lines, in yeast, and in vivo.
    Mbefo MK; Fares MB; Paleologou K; Oueslati A; Yin G; Tenreiro S; Pinto M; Outeiro T; Zweckstetter M; Masliah E; Lashuel HA
    J Biol Chem; 2015 Apr; 290(15):9412-27. PubMed ID: 25657004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?
    Olanow CW; Brundin P
    Mov Disord; 2013 Jan; 28(1):31-40. PubMed ID: 23390095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotine slows down oligomerisation of α-synuclein and ameliorates cytotoxicity in a yeast model of Parkinson's disease.
    Kardani J; Sethi R; Roy I
    Biochim Biophys Acta Mol Basis Dis; 2017 Jun; 1863(6):1454-1463. PubMed ID: 28167231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug uptake, lipid rafts, and vesicle trafficking modulate resistance to an anticancer lysophosphatidylcholine analogue in yeast.
    Cuesta-Marbán Á; Botet J; Czyz O; Cacharro LM; Gajate C; Hornillos V; Delgado J; Zhang H; Amat-Guerri F; Acuña AU; McMaster CR; Revuelta JL; Zaremberg V; Mollinedo F
    J Biol Chem; 2013 Mar; 288(12):8405-8418. PubMed ID: 23335509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships between the sequence of alpha-synuclein and its membrane affinity, fibrillization propensity, and yeast toxicity.
    Volles MJ; Lansbury PT
    J Mol Biol; 2007 Mar; 366(5):1510-22. PubMed ID: 17222866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular α-synuclein drives sphingosine 1-phosphate receptor subtype 1 out of lipid rafts, leading to impaired inhibitory G-protein signaling.
    Badawy SMM; Okada T; Kajimoto T; Hirase M; Matovelo SA; Nakamura S; Yoshida D; Ijuin T; Nakamura SI
    J Biol Chem; 2018 May; 293(21):8208-8216. PubMed ID: 29632069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease.
    Chen L; Feany MB
    Nat Neurosci; 2005 May; 8(5):657-63. PubMed ID: 15834418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms of alpha-synuclein neurodegeneration.
    Waxman EA; Giasson BI
    Biochim Biophys Acta; 2009 Jul; 1792(7):616-24. PubMed ID: 18955133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. alpha-Synuclein, oxidative stress and apoptosis from the perspective of a yeast model of Parkinson's disease.
    Witt SN; Flower TR
    FEMS Yeast Res; 2006 Dec; 6(8):1107-16. PubMed ID: 17156009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.